2021. Tolvaptan to Achieving High Urine Output and Avoiding Hyponatremia in COVID-19 with ADHF Patient: Case Report. World Journal of Current Medical and Pharmaceutical Research. 3, 5 (Oct. 2021), 123–126. DOI:https://doi.org/10.37022/wjcmpr.v3i5.195.